SAFETY AND TOLERABILITY OF LIVER-DERIVED STEM CELLS (HEPASTEM (TM)) INFUSED IN PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) OR ACUTE DECOMPENSATION (AD) AT RISK OF DEVELOPING ACLF: A EUROPEAN PHASE I/IIa OPEN-LABELLED STUDY-MedSci.cn

SAFETY AND TOLERABILITY OF LIVER-DERIVED STEM CELLS (HEPASTEM (TM)) INFUSED IN PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) OR ACUTE DECOMPENSATION (AD) AT RISK OF DEVELOPING ACLF: A EUROPEAN PHASE I/IIa OPEN-LABELLED STUDY

Nevens, F; Laterre, PF; Lasser, LL; Haralampiev, L; Vargas, V; Lyubomirova, D; Albillos, A; Barthel, V; Clerget, N; Sokal, EM

HEPATOLOGY, 2019; 70 (): 71A

科室
- - 订阅+
  - 更多科室
工具
服务